TFO Wealth Partners’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-8
Closed -$6.22K 458
2024
Q1
$6.22K Sell
8
-1
-11% -$712 ﹤0.01% 102
2023
Q4
$5.25K Hold
9
﹤0.01% 109
2023
Q3
$4.22K Buy
9
+1
+13% +$515 ﹤0.01% 179
2023
Q2
$3.75K Sell
8
-299
-97% -$125K ﹤0.01% 172
2023
Q1
$105K Buy
307
+285
+1,295% +$96.1K 0.02% 54
2022
Q4
$709 Buy
+22
New +$7.8K ﹤0.01% 427
2022
Q3
Sell
-51
Closed -$17K 329
2022
Q2
$17K Buy
+51
New +$15.3K ﹤0.01% 92

Other funds holding LLY

TFO Wealth Partners's LLY Position: Q2 2024 in Review

TFO Wealth Partners sold out of Eli Lilly (LLY) in Q2 2024, closing a stake of 8 shares — an estimated $6.22K sold.

TFO Wealth Partners first reported a position in LLY in Q2 2022 and held it in 7 quarters. The position peaked at $105K in Q1 2023. 3,564 funds tracked by Wall St. Rank hold LLY as of Q2 2024.

  • TFO Wealth Partners reported no remaining Eli Lilly position as of Q2 2024 after selling out during the quarter.
  • TFO Wealth Partners sold 8 Eli Lilly shares in Q2 2024, an estimated $6.22K.
  • TFO Wealth Partners first reported a position in Eli Lilly in Q2 2022 and held it in 7 quarters.
  • TFO Wealth Partners's Eli Lilly position peaked at $105K in Q1 2023.
  • 3,564 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2024.

Based on TFO Wealth Partners's 13F filing for Q2 2024, filed 15 Aug 2024.